Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa

South African Medical Journal

Volumn 98, Issue 8, 2008, Pages 626-632

  Perovic, Olga ^a   Koornhof, H J ^b   Crewe Brown, H H ^a   Duse, A G ^a   van Nierop, W ^b   Galpin, J S ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURN; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FATALITY; FEMALE; GENOTYPE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PEDIATRIC WARD; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RESTRICTION MAPPING; SOUTH AFRICA; TERTIARY HEALTH CARE; ADOLESCENT; EPIDEMIC; GRAM NEGATIVE INFECTION; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HEALTH SURVEYS; HUMANS; MALE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 55949110660     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kuikka A, Valtonen VV. Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1998; 17: 701-708.
2. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Circular trends in rates, mortality and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177-1184.
3. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
4. Dropulic LK, Leslie JM, Lois J, Eldred LJ, Zenilman J, Sears CL. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995; 171: 930-937.
5. Vidal F, Mensa J, Martinez JA, et al. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 1999; 18: 473-477.
6. Fergie JE, Shema SJ, Lott L, Crawford R, Patrick CC. Pseudomonas aeruginosa bacteraemia in immunocompromised children: analysis of factors associated with a poor outcome. Clin Infect Dis 1994; 18: 390-394.
7. Kang C-I, Kim S-H, Kim H-B, et al. Pseudomonas aeruginosa bacteraemia: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy or clinical outcome. Clin Infect Dis 2003; 37: 745-751.
8. Flores G. Stavola JJ, Noel GJ. Bacteraemia due to Pseudomonas aeruginosa in childbirth with AIDS. Clin Infect Dis 1993; 16: 706-708.
9. Leigh L, Stoll BJ, Rahman M, McGowan J. Pseudomonas aeruginosa infection in very low birth weight infants: a case-control study. Pediatr Infect Dis J 1995; 14 (5): 367-371.
10. Huang Y-C, Lin T-Y, Wang C-H. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr Infect Dis J 2002; 21: 1049-1052.
11. Struelens MJ. Schwam V, Deplano A, Baran D. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 1993; 31(9): 2320-2326.
12. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233-2239.
13. Talon D, Cailleaux V, Thouverez M, Michel-Brand Y. Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J Hospital Infect 1996; 32: 135-145.
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard M7-A4, 1997.
15. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infectious in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000; 19(12): 915-925.
16. McManus AT, Mason AD, McManus WF, Privitt JBA. Twenty-five year review of Pseudomonas aeruginosa bacteraemia in a burn center. Eur J Clin Microbiol 1985; 4: 219-223.
17. Foca M, Jakob K, Whitter S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000; 343: 695-700.
18. Tsai MJ, Teng CJ, Teng RJ, Lee PI, Chang MH. Necrotizing bowel lesions complicated by Pseudomonas septicaemia in previously healthy infants. Eur J Pediatr 1996; 40: 233-236.
19. Yeung CK, Lee KH. Community-acquired fulminant Pseudomonas infection of the gastrointestinal tract in previously healthy infants. J Pediatr Child Health 1998; 34: 584-587.
20. Lode H. Hamacher L. Eller J. Schaberg T. Changing role of carbapenems in the treatment of lower respiratory tract infections. Scand J Infect Dis 1995; 96: suppl, 17-23.
21. Par GB, Ramphal R. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 1996: 2587-2615.
22. Norrby SN. Integrons: Adding another threat to the use of antibiotic therapy. Clin Infect Dis 2005; 41: 10-11.
23. Pitten F-A, Panzig B, Schröder G, Tietze K, Kramer A. Transmission of a multiresistant Pseudomonas aeruginosa strain at a German university hospital. J Hosp Infect 2001; 47: 125-130.
24. Richard P, Le Floch R, Chamoux C, Parrier M, Espaze E, Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994; 170: 377-384.
25. Hsueh P-R, Teng L-J, Yang P-C, Chen Y-C, Ho S-W, Luh K-T. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol 1998; 36: 1347-1351.